Nintedanib 100 MG Oral Capsule — RxCUI 1592742
RxNorm drug concept · Semantic clinical drug
RxCUI 1592742
Semantic clinical drug · SCD
● Current RxNorm concept 16 FDA products
16 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1592742
Official nameNintedanib 100 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asnintedanib 100 MG (as nintedanib ethanesulfonate 120.4 MG) Oral Capsule
FDA products mapped16
Package NDCs mapped16
Reported Medicaid activity (SDUD)7,483 prescriptions · 33 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Nintedanib: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats scarring lung diseases in adults. That includes idiopathic pulmonary fibrosis and other chronic fibrosing interstitial lung diseases that keep getting worse. Some product...
- Take them twice a day, about 12 hours apart, with food. Swallow them whole with liquid. Don't chew, open or crush them. If you miss a dose, just take the next one at the usual time...
- Diarrhea is the big one, and nausea, vomiting, belly pain, and less appetite are common too. Tell us early about diarrhea so we can help with fluids and medicine like loperamide. C...
- Nintedanib can affect your liver, mostly in the first three months. We check liver tests before you start, regularly early on, and periodically afterward. Call us if you notice dar...
🕸️ Concept Web — How Nintedanib 100 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Nintedanib 100 MG Oral Capsule
RxCUI 1592742 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Nintedanib
1592737IN
-
Nintedanib
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Ofev
1592743BN
-
Ofev
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Nintedanib Oral Capsule
1592741SCDF -
Nintedanib Oral Product
1592739SCDG -
Nintedanib Pill
1592740SCDG -
Nintedanib Oral Capsule [Ofev]
1592745SBDF -
Ofev Oral Product
1592746SBDG -
Ofev Pill
1592747SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Nintedanib Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Nintedanib 100 MG
1592738SCDC -
Nintedanib 100 MG Oral Capsule [Ofev]
1592748SBD -
Nintedanib 100 MG [Ofev]
1592744SBDC
-
Nintedanib 100 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Nintedanib 100 MG
SCDC · 1592738 -
Nintedanib Oral Capsule
SCDF · 1592741 -
Nintedanib Oral Product
SCDG · 1592739 -
Nintedanib Pill
SCDG · 1592740
Brand-Name Concepts
-
Nintedanib 100 MG Oral Capsule [Ofev]
SBD · 1592748 -
Nintedanib 100 MG [Ofev]
SBDC · 1592744 -
Nintedanib Oral Capsule [Ofev]
SBDF · 1592745 -
Ofev Oral Product
SBDG · 1592746 -
Ofev Pill
SBDG · 1592747 -
Ofev
BN · 1592743
📦 FDA Products & Package NDCs
16 products · 16 package NDCs
16 package NDCs map to RxCUI 1592742 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00597-0143-60 | 1 BOTTLE in 1 CARTON (0597-0143-60) / 60 CAPSULE in 1 BOTTL... | Ofev | Boehringer Ingelheim Pharmaceuticals, Inc. | 2014-10-17 |
| 00597-0145-60 | 1 BOTTLE in 1 CARTON (0597-0145-60) / 60 CAPSULE in 1 BOTTL... | Ofev | Boehringer Ingelheim Pharmaceuticals, Inc. | 2014-10-17 |
| 00781-2492-60 | 60 CAPSULE in 1 BOTTLE (0781-2492-60) | nintedanib | Sandoz Inc | 2026-04-02 |
| 00781-2495-60 | 60 CAPSULE in 1 BOTTLE (0781-2495-60) | nintedanib | Sandoz Inc | 2026-04-02 |
| 42799-0972-01 | 60 CAPSULE in 1 BOTTLE (42799-972-01) | Nintedanib | Edenbridge Pharmaceuticals LLC. | 2026-04-03 |
| 42799-0973-01 | 60 CAPSULE in 1 BOTTLE (42799-973-01) | Nintedanib | Edenbridge Pharmaceuticals LLC. | 2026-04-03 |
| 43598-0147-60 | 60 CAPSULE in 1 BOTTLE (43598-147-60) | Nintedanib | Dr. Reddy's Laboratories Inc. | 2026-04-02 |
| 43598-0148-60 | 60 CAPSULE in 1 BOTTLE (43598-148-60) | Nintedanib | Dr. Reddy's Laboratories Inc. | 2026-04-02 |
| 51407-0984-60 | 60 CAPSULE in 1 BOTTLE (51407-984-60) | Nintedanib | Golden State Medical Supply, Inc. | 2026-02-15 |
| 51407-0985-60 | 60 CAPSULE in 1 BOTTLE (51407-985-60) | Nintedanib | Golden State Medical Supply, Inc. | 2026-02-15 |
| 60505-4818-06 | 1 BOTTLE in 1 CARTON (60505-4818-6) / 60 CAPSULE in 1 BOTTL... | Nintedanib | Apotex Corp. | 2026-04-02 |
| 60505-4819-06 | 1 BOTTLE in 1 CARTON (60505-4819-6) / 60 CAPSULE in 1 BOTTL... | Nintedanib | Apotex Corp. | 2026-04-02 |
| 69097-0639-03 | 60 CAPSULE in 1 BOTTLE (69097-639-03) | Nintedanib | Cipla USA Inc. | 2026-04-02 |
| 69097-0641-03 | 60 CAPSULE in 1 BOTTLE (69097-641-03) | Nintedanib | Cipla USA Inc. | 2026-04-02 |
| 76282-0786-60 | 60 CAPSULE in 1 BOTTLE (76282-786-60) | Nintedanib Capsules, 100 mg and 150 mg | EXELAN PHARMACEUTICALS INC. | 2026-05-07 |
| 76282-0787-60 | 60 CAPSULE in 1 BOTTLE (76282-787-60) | Nintedanib Capsules, 100 mg and 150 mg | EXELAN PHARMACEUTICALS INC. | 2026-05-07 |
Observed labelers:
Apotex Corp. (2) ·
Boehringer Ingelheim Pharmaceuticals, Inc. (2) ·
Cipla USA Inc. (2) ·
Dr. Reddy's Laboratories Inc. (2) ·
Edenbridge Pharmaceuticals LLC. (2) ·
EXELAN PHARMACEUTICALS INC. (2)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.